8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  September 29, 2006

BAUSCH & LOMB INCORPORATED
(Exact name of registrant as specified in its charter)

New York	1-4105	16-0345235
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)
One Bausch & Lomb Place, Rochester, NY			14604-2701
(Address of principal executive offices)			(Zip Code)

Registrant’s telephone number, including area code: (585) 338.6000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01Other Events.

On September 29, 2006, the Company announced that its request for an additional trading period was granted by the New York Stock Exchange.  Details of the announcement appear in the Company’s September 29, 2006 press release, a copy of which is attached as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

(a)	Financial statements of businesses acquired.
	—Not applicable
(b)	Pro forma financial information.
	—Not applicable
(c)	Exhibits. The following exhibit is furnished as part of this report:
	99.1 Press Release dated September 29, 2006.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BAUSCH & LOMB INCORPORATED

          /s/ ROBERT B. STILES

Robert B. Stiles

Senior Vice President and General Counsel

Date: September 29, 2006

3

EX-99.1

Exhibit 99.1

News

Bausch & Lomb Obtains New York Stock Exchange Listing Extension

FOR RELEASE FRIDAY, SEPTEMBER 29, 2006

ROCHESTER, N.Y. — Bausch & Lomb (NYSE: BOL) today announced that it has received a three-month extension for continued listing and trading on the New York Stock Exchange (NYSE). The extension, which is subject to review by the NYSE on an ongoing basis, provides the Company until January 2, 2007 to file its Annual Report on Form 10-K for the year ended December 31, 2005 with the Securities and Exchange Commission. During the period, trading of the Company’s shares on the NYSE will remain unaffected. If Bausch & Lomb does not make this filing by January 2, 2007, the Exchange could either grant an additional extension of up to three months or move forward with the initiation of suspension and delisting procedures.

Bausch & Lomb indicated that it is working diligently to complete all of the ongoing work described in its August 8, 2006 Form 12b-25, and that it will file the Annual Report on Form 10-K for fiscal year 2005 as soon as practicable.

###

News Media Contact:

Barbara M. Kelley

585.338.5386

bkelley@bausch.com

Investor Relations Contact:

Daniel L. Ritz

585.338.5802

dritz@bausch.com

This news release contains, among other things, certain statements of a forward-looking nature relating to future events or the future business performance of Bausch & Lomb.  Such statements involve a number of risks and uncertainties including those concerning economic conditions, currency exchange rates, product development and introduction, the financial well-being of key customers, the successful execution of marketing strategies, the continued successful implementation of its efforts in managing and reducing costs and expenses, as well as the risk factors listed from time to time in the Company’s SEC filings, including but not limited to filings on Form 8-K and on Form 12b-25, each dated August 8, 2006.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world.  Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products.  The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world.  Founded in 1853, the Company is headquartered in Rochester, New York.  Bausch & Lomb’s 2004 revenues were $2.2 billion; it employs approximately 13,700 people worldwide and its products are available in more than 100 countries.  More information about the Company is on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb Incorporated.